The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Abstract
BACKGROUND: The pathophysiology of heart failure with normal ejection fraction (HFNEF) is still under discussion. Here we report the influence of cardiac inflammation on extracellular matrix (ECM) remodeling in patients with HFNEF. METHODS AND RESULTS: We investigated left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control patients by conductance catheter methods and echocardiography. Endomyocardial biopsy samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were investigated. Primary human cardiac fibroblasts were outgrown from the endomyocardial biopsy samples to investigate the gene expression of ECM proteins after stimulation with transforming growth factor-β. Diastolic dysfunction was present in the HFNEF patients compared with the control patients. In endomyocardial biopsy samples from HFNEF patients, we found an accumulation of cardiac collagen, which was accompanied by a decrease in the major collagenase system (matrix metalloproteinase-1) in the heart. Moreover, a subset of inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, could be documented in the HFNEF patients. Stimulation of primary human cardiac fibroblasts from HFNEF patients with transforming growth factor-β resulted in transdifferentiation of fibroblasts to myofibroblasts, which produced more collagen and decreased the amount of matrix metalloproteinase-1, the major collagenase in the human heart. A positive correlation between cardiac collagen, as well as the amount of inflammatory cells, and diastolic dysfunction was evident and suggests a direct influence of inflammation on fibrosis triggering diastolic dysfunction. CONCLUSIONS: Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The last two alterations are likely triggered by microvascular endothelial inflammation [70].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [70]
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
Self-citationOutcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,959
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,139
Souders, C. A., Bowers, S., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 1,018
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 735
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Borlaug, B. A., Melenovsky, V., Russell, S. D., Kessler, K., Pacak, K., Becker, L. C., & Kass, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.632745 · Cited by 699
Cited by
Sorted by citations
Items 201–300 of 638
Myocardial reverse remodeling: how far can we rewind?
Gonçalves‐Rodrigues, P., Leite-Moreira, A. F., & Falcão‐Pires, I. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00696.2015 · Cited by 48
Li, C., Qin, D., Hu, J., Yang, Y., Hu, D., & Yu, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947147 · Cited by 44
Werbner, B., Tavakoli‐Rouzbehani, O. M., Fatahian, A. N., & Boudina, S. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.42 · Cited by 44
Inflammation as a therapeutic target in heart failure with preserved ejection fraction
Peh, Z. H., Dihoum, A., Hutton, D. L., Arthur, J. S. C., Rena, G., Khan, F., Lang, C. C., & Mordi, I. R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1125687 · Cited by 46
Hung, C., Chou, C., Liao, C., Lin, Y.-T., Wu, X.-M., Chang, Y., Chen, Y.-H., Wu, V., Su, M., Ho, Y., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06768 · Cited by 44
Cardiac (myo)fibroblasts modulate the migration of monocyte subsets
Pappritz, K., Savvatis, K., Koschel, A., Miteva, K., Tschöpe, C., & Linthout, S. V. (2018) · Scientific Reports · doi:10.1038/s41598-018-23881-7 · Cited by 46
Self-citationJu, C., Zhou, J., Lee, S., Tan, M., Liu, T., Bazoukis, G., Jeevaratnam, K., Chan, E. W., Wong, I. C. K., Wei, L., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13358 · Cited by 44
Targeting the vasculature in cardiometabolic disease
Boutagy, N. E., Singh, A. K., & Sessa, W. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148556 · Cited by 45
Phosphodiesterase in heart and vessels: from physiology to diseases
Fu, Q., Wang, Y., Chen, Y., & Xiang, Y. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00015.2023 · Cited by 44
Bielecka-Dabrowa, A. M., Sakowicz, A., Misztal, M., von Haehling, S., Ahmed, A., Pietrucha, T., Rysz, J., & Banach, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.150 · Cited by 43
Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension
Mazurek, J. A., Horne, B. D., Saeed, W., Sardar, M. R., & Zolty, R. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.12.012 · Cited by 43
CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis
Müller, I., Pappritz, K., Savvatis, K., Puhl, K., Dong, F., El-Shafeey, M. E. A., Hamdani, N., Hamann, I., Noutsias, M., Infante‐Duarte, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182643 · Cited by 43
Self-citationTreating Heart Failure with Preserved Ejection Fraction: Learning from Pulmonary Fibrosis
Graziani, F., Varone, F., Crea, F., & Richeldi, L. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1286 · Cited by 44
Distinctive patterns of inflammation across the heart failure syndrome
Schiattarella, G. G., Sequeira, V., & Ameri, P. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09949-5 · Cited by 46
The Impact of Platelet Indices on Clinical Outcome in Heart Failure: Results from the MyoVasc Study
Dahlen, B., Schulz, A., Göbel, S., Tröbs, S., Schwuchow‐Thonke, S., Spronk, H. M. H., Prochaska, J. H., Arnold, N., Lackner, K. J., Gori, T., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13390 · Cited by 47
Angelis, A. D., Cappetta, D., Piegari, E., Rinaldi, B., Ciuffreda, L. P., Esposito, G., Ferraiolo, F. A. V., Rivellino, A., Russo, R., Donniacuo, M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.168 · Cited by 43
The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells
Sun, Z., Schriewer, J. M., Tang, M., Marlin, J. W., Taylor, F. R., Shohet, R. V., & Konorev, E. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.010 · Cited by 45
Biasucci, L. M., Rosa, G. L., Pedicino, D., d’Aiello, A., Galli, M., & Liuzzo, G. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0896-0 · Cited by 42
Bai, B., Cheng, M., Jiang, L., Xu, J., Chen, H., & Xu, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.614757 · Cited by 43
A Review of the DASH Diet as an Optimal Dietary Plan for Symptomatic Heart Failure
Rifai, L., & Silver, M. A. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.11.001 · Cited by 39
MiRNA Deregulation in Cardiac Aging and Associated Disorders
Verjans, R., van Bilsen, M., & Schroen, B. L. M. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.004 · Cited by 39
MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
Kobusiak−Prokopowicz, M., Krzysztofik, J., Kaaz, K., Jołda-Mydłowska, B., & Mysiak, A. (2018) · Open Medicine · doi:10.1515/med-2018-0037 · Cited by 39
Aging, MicroRNAs, and Heart Failure
Florio, M. C., Magenta, A., Beji, S., Lakatta, E. G., & Capogrossi, M. C. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.12.003 · Cited by 40
Tank, J., Lindner, D., Wang, X., Stroux, A., Gilke, L., Gast, M., Zietsch, C., Skurk, C., Scheibenbogen, C., Klingel, K., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.004 · Cited by 39
Self-citationVilahur, G., Casaní, L., Peña, E., Crespo, J., Juan‐Babot, O., Ben‐Aicha, S., Mendieta, G., Béjar, M. T., Borrell-Pagés, M., & Badimón, L. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.030 · Cited by 38
Karakasis, P., Fragakis, N., Patoulias, D., Theofilis, P., Sagris, Μ., Koufakis, T., Vlachakis, P. K., Rangraze, I. R., El‐Tanani, M., Tsioufis, K. P., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092112 · Cited by 37
von Bibra, H., Paulus, W. J., Sutton, M. S. J., Leclerque, C., Schuster, T., & Schumm‐Draeger, P. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.005 · Cited by 37
Coromilas, E. J., Que-Xu, E.-C., Moore, D., Kato, T., Wu, C. C. N., Ji, R., Givens, R. C., Jorde, U. P., Takayama, H., Naka, Y., et al. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0298-z · Cited by 37
Steffens, S., Linthout, S. V., Sluijter, J. P. G., Tocchetti, C. G., Thum, T., & Madonna, R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa137 · Cited by 38
Mengozzi, A., Pugliese, N. R., Chiriacò, M., Masi, S., Virdis, A., & Taddei, S. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001109 · Cited by 37
Fu, B., Wei, X., Lin, Y., Chen, J.-Y., & Yu, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.731059 · Cited by 37
Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis
Trial, J., Heredia, C. P., Taffet, G. E., Entman, M. L., & Cieslik, K. A. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0623-4 · Cited by 37
The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
Weerts, J., Mourmans, S. G. J., Aizpurua, A. B., Schroen, B. L. M., Knackstedt, C., Eringa, E. C., Houben, A. J. H. M., & van Empel, V. P. M. (2022) · Biomolecules · doi:10.3390/biom12020278 · Cited by 37
Yoshida, S., Yoshida, T., Inukai, K., Kato, K., Yura, Y., Hattori, T., Enomoto, A., Ohashi, K., Okumura, T., Ouchi, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52068-0 · Cited by 35
Insights into cardiac involvement in ankylosing spondylitis from cardiovascular magnetic resonance
Biesbroek, P. S., Heslinga, S. C., Konings, T. C., van der Horst-Bruinsma, I. E., Hofman, M. B. M., van de Ven, P. M., Kamp, O., van Halm, V. P., Peters, M. J. L., Smulders, Y. M., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-310667 · Cited by 35
Ovchinnikov, A. G., Arefieva, T. I., Potekhina, A. V., Filatova, A. Y., Ageev, F. T., & Boytsov, S. A. (2020) · Acta Naturae · doi:10.32607/actanaturae.10990 · Cited by 36
Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure
Soetkamp, D., Gallet, R., Parker, S. J., Holewinski, R. J., Venkatraman, V., Peck, K. A., Goldhaber, J. I., Marbán, E., & Eyk, J. E. V. (2021) · Circulation Research · doi:10.1161/circresaha.119.316311 · Cited by 37
Intercellular Signalling Cross-Talk: To Kill, To Heal and To Rejuvenate
Plotnikov, E. Y., Silachev, D. N., Popkov, V. A., Zorova, L. D., Pevzner, I. B., Zorov, S. D., Jankauskas, S. S., Babenko, V. A., Sukhikh, G. T., & Zorov, D. B. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.12.002 · Cited by 35
Maione, A. S., Stadiotti, I., Pilato, C. A., Perrucci, G. L., Saverio, V., Catto, V., Vettor, G., Casella, M., Guarino, A., Polvani, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052673 · Cited by 34
Cardiac fibroblasts in myocardial injury and heart failure
Linthout, S. V., Matz, I., González, A., & Davis, J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf902 · Cited by 38
Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation
Arêas, G. P. T., Mazzuco, A., Caruso, F., Jaenisch, R. B., Cabiddu, R., Phillips, S. A., Arena, R. A., & Borghi‐Silva, A. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9719-7 · Cited by 34
Drapkina, O. M., & Dzhioeva, O. N. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2020-2454 · Cited by 32
A change of heart: oxidative stress in governing muscle function?
Breitkreuz, M., & Hamdani, N. (2015) · Biophysical Reviews · doi:10.1007/s12551-015-0175-5 · Cited by 32
Voss, S., Krüger, S., Scherschel, K., Warnke, S., Schwarzl, M., Schrage, B., Girdauskas, E., Meyer, C. G., Blankenberg, S., Westermann, D., et al. (2019) · Biomolecules · doi:10.3390/biom9020038 · Cited by 32
Self-citationUnudurthi, S. D., Nassal, D. M., Patel, N., Thomas, E., Yu, J., Pierson, C. G., Bansal, S. S., Mohler, P. J., & Hund, T. J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117440 · Cited by 32
Adekunle, A. O., Adzika, G. K., Mprah, R., Noah, M. L. N., Adu‐Amankwaah, J., Rizvi, R., Akhter, N., & Sun, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.685996 · Cited by 32
Severino, P., D’Amato, A., Prosperi, S., Myftari, V., Colombo, L., Tomarelli, E., Piccialuti, A., Pietro, G. D., Birtolo, L. I., Maestrini, V., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103586 · Cited by 32
Vitorino, T. R., do Prado, A. F., Cáu, S. B. D. A., & Rizzi, É. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115684 · Cited by 33
Jin, Y., Wu, Z., Wang, N., Duan, S., Wu, Y., Wang, J., Wu, W., & Feng, F. (2016) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21806 · Cited by 32
Guo, F., Qiu, X., Tan, Z., Li, Z., & Ouyang, D. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01669-w · Cited by 31
Genetzakis, E., Gilchrist, J., Kassiou, M., & Figtree, G. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108228 · Cited by 32
Patel, R. B., & Shah, S. J. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021136 · Cited by 31
Shooshtarian, A. K., O’Gallagher, K., Shah, A. M., & Zhang, M. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10487-1 · Cited by 31
Circulating Biomarkers in Patients with Heart Failure and Preserved Ejection Fraction
O’Meara, E., de Denus, S., Rouleau, J. L., & Desai, A. S. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0160-x · Cited by 30
Rusu, M., Hilse, K., Schuh, A., Märtin, L., Slabu, I., Stoppe, C., & Liehn, E. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-53351-7 · Cited by 30
Kocaman, S. A., Durakoğlugil, M. E., Çetın, M., Erdoğan, T., Ergül, E., & Çanğa, A. (2013) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e32835ebbb5 · Cited by 30
Hung, C., Chou, C., Wu, X., Chang, Y., Wu, V., Chen, Y., Chang, Y.-S., Tsai, Y., Su, M., Ho, Y., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000619 · Cited by 30
Heart Failure With Preserved Ejection Fraction
Kitzman, D. W., & Upadhya, B. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.007 · Cited by 30
Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats
Che, Y., She, Z., Wang, Z., Jin, Y., Wu, Q., Wang, S., & Yuan, Y. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1198-9 · Cited by 29
Tourki, B., & Halade, G. V. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.695952 · Cited by 31
Glezeva, N., Collier, P. H., Voon, V., Ledwidge, M. T., McDonald, K., Watson, C. J., & Baugh, J. A. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9456-1 · Cited by 29
de Denus, S., Lavoie, J., Ducharme, A., O’Meara, E., Racine, N., Sirois, M. G., Neagoe, P., Zhu, L., Rouleau, J. L., & White, M. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.09.007 · Cited by 28
Zhang, Z., Ravassa, S., Yang, W., Petit, T., Pejchinοvski, M., Zürbig, P., López, B., Wei, F., Pontillo, C., Thijs, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167582 · Cited by 28
Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy
Jellis, C. L., Sacre, J. W., Wright, J., Jenkins, C., Haluska, B. A., Jeffriess, L., Martin, J. H., & Marwick, T. H. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu013 · Cited by 28
Wu, C., Su, M.-Y. M., Wu, Y., Hwang, J., & Lin, L. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110427 · Cited by 27
Wang, M., Shan, Y., Wu, C., Cao, P., Sun, W., Han, J., Shen, L., Chen, J., Yu, P., & Chen, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.626375 · Cited by 27
A Central Role for Monocyte–Platelet Interactions in Heart Failure
Glezeva, N., Gilmer, J. F., Watson, C. J., & Ledwidge, M. T. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415609436 · Cited by 28
Tschöpe, C., Linthout, S. V., & Kherad, B. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0874-6 · Cited by 27
Self-citationObesity and heart failure with preserved ejection fraction: A growing problem
Prenner, S. B., & Mather, P. J. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.12.003 · Cited by 27
Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF)
Jyotsna, F., Mahfooz, K., Sohail, H., Kumar, S., Adeeb, M., Dev, A., Kumar, R., Rekha, F., Varrassi, G., Khatri, M., et al. (2023) · Cureus · doi:10.7759/cureus.43279 · Cited by 26
Kato, T., Chokshi, A. D., Singh, P., Khawaja, T., Iwata, S., Homma, S., Akashi, H., Cheema, F. H., Yang, J. A., Takayama, H., et al. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.10.007 · Cited by 26
Miteva, K., Linthout, S. V., Pappritz, K., Müller, I., Spillmann, F., Haag, M., Stachelscheid, H., Ringe, J., Sittinger, M., & Tschöpe, C. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0031 · Cited by 26
Self-citationMokotedi, L. P., Michel, F. S., Mogane, C., Gomes, M., Woodiwiss, A. J., Norton, G. R., & Millen, A. M. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230657 · Cited by 29
Liang, Y., Wang, B., Huang, H., Wang, M., Wu, Q., Zhao, Y., & He, Y. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.388 · Cited by 26
Mooney, L., Goodyear, C. S., Chandra, T., Kirschner, K., Copland, M., Petrie, M. C., & Lang, N. N. (2021) · Clinical Science · doi:10.1042/cs20200306 · Cited by 28
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction
Ananthram, M. G., & Gottlieb, S. S. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.03.005 · Cited by 28
Yu, W., Jiang, Y., Xu, H., & Zhou, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11020442 · Cited by 26
Causes and Pathophysiology of Heart Failure with Preserved Ejection Fraction
Kov́acs, Á., Papp, Z., & Nagy, L. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.04.002 · Cited by 25
Phenotyping in heart failure with preserved ejection fraction: A key to find effective treatment
Zawadzka, M., Grabowski, M., & Kapłon‐Cieślicka, A. (2022) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/149728 · Cited by 25
Ye, B., Bradshaw, A. D., Abrahante, J. E., Dragon, J. A., Häußler, T. N., Bell, S., Hirashima, F., LeWinter, M. M., Zile, M. R., & Meyer, M. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010395 · Cited by 25
Recent Advances in Microbiota-Associated Metabolites in Heart Failure
Masenga, S., Povia, J. P., Lwiindi, P., & Kirabo, A. (2023) · Biomedicines · doi:10.3390/biomedicines11082313 · Cited by 28
Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives
Ovchinnikov, A. G., Potekhina, A. V., Arefieva, T. I., Filatova, A. Y., Ageev, F. T., & Belyavskiy, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094958 · Cited by 26
Sodium Restriction in Heart Failure: Benefit or Harm?
Konerman, M. C., & Hummel, S. L. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0286-x · Cited by 25
Left atrial changes in early stages of heart failure with preserved ejection fraction
Bytyçi, I., & Bajraktari, G. (2016) · Echocardiography · doi:10.1111/echo.13306 · Cited by 25
del Villar, C. P., Savvatis, K., López, B., Kašner, M., Martínez‐Legazpi, P., Yotti, R., González, A., Dı́ez, J., Fernández‐Avilés, F., Tschöpe, C., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx047 · Cited by 25
Self-citationSilva, M. C., Davoli-Ferreira, M., Medina, T. D. S., Sesti‐Costa, R., Silva, G. K., Lopes, C. D., Cardozo, L. E., Gava, F. N., Lyroni, K., Dias, F. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03986-3 · Cited by 25
Wang, X., Chen, X., Wang, Y., He, X., Li, L., Wang, X., Huang, Y., Fan, G., & Ni, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1467132 · Cited by 24
Taylor, E. B., Hall, J. E., & Mouton, A. J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107761 · Cited by 25
Gan, W., Li, T., Ren, J., Li, C., Liu, Z., & Yang, M. H. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3252-1 · Cited by 24
Zhou, G., Jiang, Y., Ma, D., Wang, Y., Jl, Y., Chen, J., Chi, C.-Y., Han, X., Li, Z., & Li, X. (2019) · BioMed Research International · doi:10.1155/2019/9637479 · Cited by 24
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
Lang, C. C., & Singh, J. S. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s55630 · Cited by 24
Effects of spironolactone in heart failure with preserved ejection fraction
Li, S., Zhang, X., Dong, M., Gong, S., Shang, Z., Xu, J., Chen, W., Yang, J., & Li, J. (2018) · Medicine · doi:10.1097/md.0000000000011942 · Cited by 24
Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
Shah, K., & Fang, J. C.-T. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0993-0 · Cited by 24
Komici, K., Conti, V., Davinelli, S., Bencivenga, L., Rengo, G., Filippelli, A., Ferrara, N., & Corbi, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2176728 · Cited by 24
Protective Function of STAT3 in CVB3-Induced Myocarditis
Lindner, D., Hilbrandt, M., Marggraf, K., Becher, P. M., Hilfiker‐Kleiner, D., Klingel, K., Pauschinger, M., Schultheiß, H., Tschöpe, C., & Westermann, D. (2012) · Cardiology Research and Practice · doi:10.1155/2012/437623 · Cited by 24
Self-citationvan Weperen, V. Y. H., & Vaseghi, M. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-01000-6 · Cited by 25
Increased Circulating Cathepsin K in Patients with Chronic Heart Failure
Zhao, G., Li, Y.-Z., Cui, L., Li, X., Jin, Z., Han, X., Fang, E., Gao, Y., Zhou, D., Jiang, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136093 · Cited by 23
Cardiovascular inflammation: RNA takes the lead
Martens, C. R., Bansal, S. S., & Accornero, F. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.03.012 · Cited by 23
Zhang, X., Zhang, Y., Sun, A., & Ge, J. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.04.001 · Cited by 24
Saavedra-Alvarez, A., Pereyra, K. V., Toledo, C., Iturriaga, R., & Río, R. D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1070935 · Cited by 23
Metadata
- Authors
- Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., Poller, W., Schultheiss, H.-P., & Tschöpe, C.
- Affiliations
- Leiden University Medical Center (NL)
- From the Department of Cardiology and Pneumology (D.W., D.L., M.K., C.Z., K.S., F.E., J.v.S., C.S., A.R., W.P., H.-P.S., C.T.), Charité, Universititäts-Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany, and Department of Cardiology (P.S.), Leiden University Medical Center, Leiden, The Netherlands.
- ORCID
- Venue
- Circulation Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2131184290
- Cited by
- 644
- References
- 55
- Citations by year
- 2026: 32 · 2025: 48 · 2024: 53 · 2023: 50 · 2022: 57 · 2021: 58 · 2020: 49 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 35 · 2015: 42 · 2014: 30 · 2013: 21 · 2012: 17
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, cardiac inflammation, extracellular matrix remodeling, diastolic dysfunction, myocardial fibrosis, collagen deposition, MMP-1, TGF-beta, myofibroblasts, endomyocardial biopsy, left ventricular systolic function
- MeSH terms
- Adult, Aged, Biopsy, Cells, Cultured, Collagen, Extracellular Matrix, Female, Fibroblasts, Fibrosis, Heart, Heart Failure, Humans, Inflammation, Male, Middle Aged, Myocardium, Stroke Volume, Case-Control Studies, Transforming Growth Factor beta, Ventricular Function, Left, Extracellular Matrix Proteins, Disease Progression, Matrix Metalloproteinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
